Table 4.
Anti-PD drugs other than levodopa; the number of patients who were taking respective drugs
| From the onset | No. | DA agonists | Trihexyphenidyl | Amantadine | Selegiline | Entacapone | Zonisamide | Istradefylline | L-dops | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 years or less | 135 | 34 | 25.2% | 57 | 42.2% | 10 | 6.3% | 9 | 6.7% | 5 | 3.7% | 10 | 7.4% | 0 | 0.0% | 0 | 0.0% |
| 6–10 years | 158 | 76 | 48.1% | 72 | 45.6% | 16 | 10.1% | 22 | 13.9% | 13 | 8.2% | 19 | 12.0% | 3 | 1.9% | 0 | 0.0% |
| 11–15 years | 114 | 76 | 48.1% | 54 | 47.4% | 27 | 23.7% | 13 | 11.4% | 19 | 16.7% | 16 | 14.0% | 4 | 3.5% | 1 | 0.9% |
| 16–20 years | 53 | 32 | 60.4% | 23 | 43.4% | 11 | 20.8% | 6 | 11.3% | 12 | 22.6% | 11 | 20.8% | 2 | 3.8% | 1 | 1.9% |
| 21 years or more | 38 | 21 | 55.3% | 18 | 47.4% | 19 | 50.0% | 1 | 2.6% | 8 | 21.1% | 8 | 21.1% | 1 | 2.6% | 0 | 0.0% |
| Total | 498 | 223 | 44.8% | 224 | 45.0% | 83 | 16.7% | 51 | 10.2% | 57 | 11.4% | 64 | 12.9% | 10 | 2.0% | 2 | 0.4% |